Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer

Background: Chimeric antigen receptor (CAR)-modified T cells have successfully harnessed T cell immunity against malignancies, but they are by no means the only cell therapies in development for cancer. Main Text Summary: Systemic immunity is thought to play a key role in combatting neoplastic disea...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Oncol
Asıl Yazarlar: Patel, Shabnum, Burga, Rachel A., Powell, Allison B., Chorvinsky, Elizabeth A., Hoq, Nia, McCormack, Sarah E., Van Pelt, Stacey N., Hanley, Patrick J., Cruz, Conrad Russell Y.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2019
Konular:
Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6467966/
https://ncbi.nlm.nih.gov/pubmed/31024832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00196
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller